Education
About Us
Working with TipRanks
Follow Us
Pyxis Oncology (PYXS)
NASDAQ:PYXS
| Dec 24 | Dec 23 | Dec 22 | Dec 21 | Dec 20 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 16.15M | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 |
| Gross Profit | $ 15.67M | $ -2.00M | $ -1.84M | $ -1.25M | $ -444.00K |
| Operating Income | $ -89.46M | $ -82.20M | $ -123.48M | $ -69.72M | $ -12.89M |
| EBITDA | $ -65.51M | $ -78.49M | $ -122.77M | $ -69.07M | $ -12.43M |
| Net Income | $ -77.33M | $ -73.79M | $ -117.95M | $ -81.54M | $ -12.76M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 126.93M | $ 119.30M | $ 179.29M | $ 274.74M | $ 8.08M |
| Total Assets | $ 157.18M | $ 173.73M | $ 211.38M | $ 280.02M | $ 10.15M |
| Total Debt | $ 20.20M | $ 21.33M | $ 18.92M | $ 165.00K | $ 780.00K |
| Net Debt | $ 727.00K | $ 11.67M | $ -160.37M | $ -274.57M | $ -7.30M |
| Total Liabilities | $ 36.43M | $ 48.02M | $ 50.55M | $ 18.71M | $ 25.80M |
| Stockholders' Equity | $ 120.75M | $ 125.70M | $ 160.82M | $ 261.31M | $ -15.64M |
| Cash Flow | |||||
| Free Cash Flow | $ -57.91M | $ -77.44M | $ -95.73M | $ -35.87M | $ -11.57M |
| Operating Cash Flow | $ -57.67M | $ -70.71M | $ -89.33M | $ -35.33M | $ -10.08M |
| Investing Cash Flow | $ 8.15M | $ -104.85M | $ -6.40M | $ -590.00K | $ -1.48M |
| Financing Cash Flow | $ 59.33M | $ 5.93M | $ 183.00K | $ 304.04M | $ 35.00K |
Pyxis Oncology Forecast EPS vs Actual EPS
Currently, no data available
Please return soon. This page is being updated.